Page last updated: 2024-08-17

physostigmine and Carcinoma, Epidermoid

physostigmine has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhuyan, BK; Buskirk, HH; Kuentzel, SL; Manak, RC; Moxley, TE; Neil, GL1

Other Studies

1 other study(ies) available for physostigmine and Carcinoma, Epidermoid

ArticleYear
Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.
    Biochemical pharmacology, 1971, Volume: 20, Issue:12

    Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Carcinoma, Squamous Cell; Cell Line; Cells, Cultured; Cycloparaffins; Cytarabine; Deamination; Delayed-Action Preparations; Depression, Chemical; DNA, Neoplasm; Half-Life; Haplorhini; Humans; Hydrolysis; In Vitro Techniques; Leukemia L1210; Mice; Neoplasm Proteins; Physostigmine; Plasma; RNA, Neoplasm; Tritium; Uridine

1971